Author: Rutali Thakur

Artificial intelligence (AI) is poised to revolutionize gastroenterology, particularly in managing inflammatory bowel disease (IBD). AI technologies, including image analysis, natural language processing (NLP), and generative AI, enhance diagnostics and patient care. AI can process complex medical images, streamline electronic medical record reviews, and provide personalized patient education. The integration of AI promises to improve detection rates, reduce clinician burnout, and enable more personalized treatment plans, potentially even leading to cures for certain IBD subtypes. The rapid advancement of AI suggests that these changes are imminent.

Read More

Gastroenterology practices face unique challenges in medical coding, which can significantly impact their revenue streams. The article from NextServices provides an in-depth guide to mastering gastroenterology coding, highlighting the most common mistakes and offering strategies to optimize billing practices. Key points include: For a comprehensive guide on mastering gastroenterology coding..

Read More

Endiatx’s swallowable robotic pill, PillBot, is entering clinical trials and preparing for FDA review, aiming for a commercial launch by early 2026. PillBot, equipped with cameras and sensors, offers a non-invasive alternative to traditional endoscopy by providing real-time imagery of the gastrointestinal tract. The company, which has raised $7 million, envisions AI integration to eventually allow autonomous navigation and diagnosis, potentially revolutionizing gastroenterology by making advanced diagnostic procedures more accessible and cost-effective.

Read More